ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 225112 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 225112; 2) Community: the network communities that were significantly associated with the response to NSC 225112; 3) Molecule: the relationships between components within communities and NSC 225112; 4) MDR: the compounds that were significantly associated with the NSC 225112.

NSC Compound Enrichment Correlation
NSC 113452 Null 0.00070132188671658 0.49372846
NSC 672140 Null 0.00070132188671658 0.43930694
NSC 725098 Null 0.00070132188671658 0.5677667
NSC 726217 Combretastatin A4-analogue 0.00070132188671658 0.41926689
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.00070132188671658 0.33828022
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.00070132188671658 0.01581819
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.000880521445136051 0.75596325
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.000880521445136051 0.41576405
NSC 757113 METHOTREXATE(+/-) 0.000880521445136051 0.78791645
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.000880521445136057 0.84910738
Total:91  Current:2    [First] [Prev] [Next] [Last]